Showing results (301-310 of 332) with videos related to
Sort By:
Pageof 34
Brain : a Journal of Neurology|June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severityEmilie Dugast, Sita Shah, Isabel Vogel, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 20, 2026
Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort StudyJulie Céline Blant, Nicola De Rossi, Ralf Gold, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2018
International consensus on quality standards for brain health-focused care in multiple sclerosisJeremy Hobart, Amy Bowen, George Pepper, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2023
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS studyMikael Cohen, Océane Thomel-Rocchi, Aksel Siva, et al.Brain : a Journal of Neurology|March 3, 2023
The radiologically isolated syndrome: revised diagnostic criteriaChristine Lebrun-Frénay, Darin T Okuda, Aksel Siva, et al.The Lancet. Neurology|December 26, 2017
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J Thompson, Brenda L Banwell, Frederik Barkhof, et al.JAMA Neurology|August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical TrialChristine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.Neurology|August 9, 2013
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patientsNicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, et al.JAMA|March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical TrialEric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2021
Determinants of therapeutic lag in multiple sclerosisIzanne Roos, Emmanuelle Leray, Federico Frascoli, et al.Pageof 34